GDKM-100
/ GD Kongming Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 18, 2023
Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells
(clinicaltrials.gov)
- P1/2 | N=0 | Withdrawn | Sponsor: Guangdong GD Kongming Biotech LLC | N=40 ➔ 0 | Recruiting ➔ Withdrawn
Enrollment change • Metastases • Trial withdrawal • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor
November 28, 2022
Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells
(clinicaltrials.gov)
- P1/2 | N=40 | Recruiting | Sponsor: Guangdong GD Kongming Biotech LLC
New P1/2 trial • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1